You searched for metabolic diseases - Page 38 of 63

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

…its potential to treat all sorts of diseases where the immune system is involved, including cancer and neurodegenerative conditions. As autoimmune diseases are directly caused by the immune system, immunotherapies…

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

…therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a tacit acknowledgment of the potential…

August 17, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 8 Jan 2018

Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA

Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to the DNA. A new research collaboration between two biotech companies…

January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2018

The 5 Best-Selling European Drugs of 2017

Biologicals have completely changed the way we treat diseases, and their growth has exploded in the last two decades. Not surprisingly, they took a whopping 7 out of 15 spots…

April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt

In Depth 11 Nov 2024

Gene editing sector investment struggles: What’s driving the slowdown?

…that the prices are justified due to the fact that they are one-time therapies that will save patients money in the long-term and the rarity of the diseases that they…

November 11, 2024 - 8 minutesmins - By Willow Shah-Neville

In Depth 27 Jun 2024

CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?

…pancreatic cancer, cervical cancer, and bladder cancer. Treating genetic diseases Although CRISPR-Cas9 is the first choice when it comes to the treatment of genetic diseases, CRISPR-Cas13 could also potentially be…

June 27, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

…where rapid genomics is becoming paramount is the fight against infectious diseases. For example, the sequencing of the coronavirus genome in 2020 turbo-charged the development of Covid-19 vaccines. And genomic…

February 10, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 22 Dec 2022

Positive Dupixent eosinophilic esophagitis phase 3 results

…drivers of the type 2 inflammation that plays a major role in multiple related and often co-morbid diseases. These diseases include approved indications for Dupixent such as asthma, atopic dermatitis,…

December 22, 2022 - 4 minutesmins - By Jim Cornall

In Depth 12 Feb 2024

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

RNA editing has recently made significant progress as a potentially safer alternative to gene editing for treating a number of genetic diseases. In December 2023, patients were dosed in the…

February 12, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 28 Jul 2020

Record Series A for Italian Biotech Funds Autoimmune Therapy

…for the inflammatory bowel diseases Crohn’s disease and ulcerative colitis. Italy does not typically see large funding rounds for biotech companies and this is the biggest Series A financing round…

July 28, 2020 - 3 minutesmins - By Helen Albert

Best in Biotech 26 Sep 2024

Europe’s rising biotech stars: 10 startups to watch in 2024

…find the links between genes and diseases in order to develop medicines that can imitate or inhibit drug targets – the proteins that code for the disease-related genes. Last month,…

September 26, 2024 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 25 Jul 2023

Molecure raises $12M and gets FDA clearance for pulmonary sarcoidosis trial

…ability to modulate macrophage activity, meaning it has the potential to be disease modifying and treat various inflammatory and fibrotic diseases which develop based on a similar molecular mechanism. “In…

July 25, 2023 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA

The 5 Best-Selling European Drugs of 2017

Gene editing sector investment struggles: What’s driving the slowdown?

CRISPR-Cas13: how does the technology compare to its famous Cas9 cousin?

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

Positive Dupixent eosinophilic esophagitis phase 3 results

RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing?

Record Series A for Italian Biotech Funds Autoimmune Therapy

Europe’s rising biotech stars: 10 startups to watch in 2024

Molecure raises $12M and gets FDA clearance for pulmonary sarcoidosis trial

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!